Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

DexCom Inc (DXCM)

Healthcare Medical Devices
83.50 $
+12.0% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns DexCom Inc (DXCM)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.6% of the shares are freely tradable; institutional investors hold 102.5%.

Ownership Structure

Institutional ownership
102.5%
Insiders
0.3%
Float
99.6%
Short % of float
5.1%
Shares Outstanding
386Mio.

Largest Shareholders

Institutions

Institutions DXCM
Name Stake (%) Shares Change (%) Date
Vanguard Group Inc 12.72 49,074,378 -0.8 12/31/2025
BlackRock Inc 10.10 38,964,371 -2.2 03/31/2026
Vanguard Capital Management, LLC 6.48 25,020,961 +0.0 03/31/2026
Vanguard Portfolio Management, LLC 4.98 19,219,953 +0.0 03/31/2026
State Street Corp 4.65 17,934,847 -0.9 03/31/2026
Baillie Gifford & Co Limited. 4.04 15,599,525 +0.3 03/31/2026
AllianceBernstein L.P. 3.35 12,923,644 +49.9 03/31/2026
Geode Capital Management, LLC 3.20 12,346,638 +12.2 03/31/2026

Funds

Funds DXCM
Name Stake (%) Shares Change (%) Date
Vanguard Total Stock Mkt Idx Inv 3.18 12,255,504 +0.2 04/30/2026
Vanguard 500 Index Investor 2.59 9,978,595 +1.8 04/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
20. Jul 2026 Sayer Kevin R Executive Chair Sell 26,756 76.32 2,041,999
15. Jul 2026 Brown Michael Jon EVP Chief Legal Compliance Off Sell 1,700 74.42 126,514

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?